CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Selvas AI Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Selvas AI Inc
401/402, 14F, Baeksang Star Twr 1 Cha
65, Digitalro 9-Gil
Phone: +82 28527788p:+82 28527788 SEOUL, 08594  South Korea Ticker: 108860108860

Business Summary
SELVAS AI Inc., formerly DIOTEK Co., Ltd., is a Korea-based company engaged in the development and provision of application solutions. Its products consist of DioPen, a handwriting recognition solution software, which recognizes characters or symbols written on touch-screen digital devices; DioDict, a electronic dictionary solution software applied to mobile terminals; DioNote, a note-taking and image editing software used for touch screen mobile devices; DioSpeech, a speech recognition software, and DioReader, a mobile optical character recognition (OCR) solution software for business card and document recognition, and dictionary search. In addition, it engages in the real estate rental business. The Company distributes its products within domestic market and to overseas markets.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/202412/31/2023Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chief Executive Officer, Director Min CheolGwak 48 9/5/2019 12/30/2011
Assistant Managing Director Dong YilKim 42 3/29/2013 3/29/2013
Assistant Managing Director Jae WuKang 47
4 additional Officers and Directors records available in full report.

Business Names
Business Name
108860
HIMS International Corporation
JAWONMEDICAL. CO. LTD.

General Information
Number of Employees: 137 (As of 12/31/2015)
Outstanding Shares: 26,914,276 (As of 9/30/2024)
Shareholders: 91,363
Stock Exchange: KDQ
Fax Number: +82 226294586


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, December 2, 2024